Patient-Reported Outcomes Favor Concizumab Prophylaxis in Hemophilia A or B - AJMC.com Managed Markets Network

[unable to retrieve full-text content]

Patient-Reported Outcomes Favor Concizumab Prophylaxis in Hemophilia A or B  AJMC.com Managed Markets Network

Comments

Popular posts from this blog

Spatial transferability of an agent-based model to simulate Taenia ... - Parasites & Vectors